Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 75
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Autoantibodies Targeting G-Protein-Coupled Receptors: Pathogenetic, Clinical and Therapeutic Implications in Systemic Sclerosis 2024 Civieri, GiovanniDoria, AndreaTona, FrancescoZanatta, Elisabetta + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time? 2024 Zanatta E. + ARTHRITIS CARE & RESEARCH - -
MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives 2023 Gasparotto, MichelaGhirardello, AnnaFranco, ChiaraCeolotto, GiulioGiannella, AlessandraIaccarino, LucaZanatta, ElisabettaDoria, AndreaGatto, Mariele + CURRENT OPINION IN RHEUMATOLOGY - -
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review 2023 M. GasparottoC. FrancoE. ZanattaA. GhirardelloM. ZenL. IaccarinoA. DoriaM. Gatto + AUTOIMMUNITY REVIEWS - -
Prevalence of diaphragm dysfunction in patients with interstitial lung disease (ILD): The role of diaphragmatic ultrasound 2023 Bernardinello, NicolCocconcelli, ElisabettaBoscolo, AnnalisaGiraudo, ChiaraZanatta, ElisabettaRea, FedericoSaetta, MarinaNavalesi, PaoloSpagnolo, Paolo + RESPIRATORY MEDICINE - -
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 2023 Zanatta E.Pigatto E.Doria A. + RMD OPEN - -
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 2023 Zanatta, Elisabetta + RMD OPEN - -
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 2023 Zanatta E.Cocconcelli E.Giraudo C.Gatto M.Martini A.Ghirardello A.Doria A.Spagnolo P.Iaccarino L. + RMD OPEN - -
Size-Exclusion Chromatography Combined with Ultrafiltration Efficiently Isolates Extracellular Vesicles from Human Blood Samples in Health and Disease 2023 Franco, ChiaraGhirardello, AnnaBertazza, LorisGasparotto, MichelaZanatta, ElisabettaIaccarino, LucaDoria, AndreaGatto, Mariele + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension 2023 De Michieli L.Perazzolo Marra M.Doria A.Zanatta E. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 2023 Zen M.Zanatta E.Doria A.Iaccarino L. + JOURNAL OF PERSONALIZED MEDICINE - -
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies 2023 Zanatta, ElisabettaMartini, AndreaTonello, MartaGatto, MarieleGiraudo, ChiaraDoria, AndreaIaccarino, Luca + DIAGNOSTICS - -
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 2023 Guiducci S.Zanatta E. + CHEST - -
Should we use nintedanib as early therapy in patients with SSc-ILD? 2023 ELISABETTA ZANATTAPAOLO SPAGNOLO + AUTOIMMUNITY REVIEWS - -
Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies 2023 Ghirardello A.Gatto M.Zanatta E.Padoan R.Gallo N.Zen M.Doria A.Iaccarino L. + DIAGNOSTICS - -
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 2022 Zanatta, ElisabettaDoria, Andrea + CURRENT PHARMACEUTICAL DESIGN - -
Late Skin Fibrosis in Systemic Sclerosis: A Study from the EUSTAR Cohort 2022 Zanatta E + RHEUMATOLOGY - -
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 2022 Zanatta E.Pigatto E.Calabrese F.Doria A. + AUTOIMMUNITY REVIEWS - -
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort 2022 Zanatta E. + THE LANCET. RHEUMATOLOGY - -
The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease 2022 Zanatta, ElisabettaMarra, Martina PerazzoloFamoso, GiuliaBalestro, ElisabettaGiraudo, ChiaraCalabrese, FiorellaRea, FedericoDoria, Andrea PHARMACEUTICALS - -
Mostrati risultati da 1 a 20 di 75
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile